Resonance Health (RHT.AX) Saham Harga
Resonance Health Harga
Pendapatan tumbuh 11,9% per tahun selama 19 tahun terakhir menjadi 15,75 Juta. AUD. Laba per saham tumbuh 3,8% per tahun selama 17 tahun terakhir. margin bersih Resonance Health saat ini 9,6%, naik dari -29,8% beberapa tahun lalu.
Harga saham Resonance Health
Model bisnis dan analisis saham Resonance Health
Pertanyaan yang sering diajukan tentang saham Resonance Health
The business model of Resonance Health Ltd focuses on providing innovative medical imaging software and services. The company aims to improve patient care and outcomes through its advanced technology solutions. Resonance Health specializes in the development and commercialization of non-invasive diagnostic tools, particularly in the field of liver and cardiac diseases. By leveraging its expertise in quantitative analysis and iron overload assessment, Resonance Health offers reliable and efficient solutions for diagnosing and managing various health conditions. The company operates by licensing its software to medical institutions and partnering with healthcare providers, ensuring widespread accessibility and utilization of its cutting-edge technologies.
Resonance Health Ltd is primarily active in the healthcare and medical technology industries.
The main competitors of Resonance Health Ltd in the market include other companies operating in the medical diagnostics and healthcare sector. Some prominent competitors are InHealth Group, Q BioMed, and Novartis AG. Resonance Health Ltd faces competition from these companies in developing innovative diagnostic solutions and providing high-quality healthcare services.
Resonance Health Ltd. is a leading provider of automated, non-invasive medical imaging software and analysis services. Founded in 1987, the company has a rich history of innovation and expertise in the field of liver and cardiac MRI imaging. Resonance Health's technology allows for accurate and reliable diagnosis of liver iron concentration and cardiac ejection fraction, essential measurements for monitoring patients with iron overload and heart conditions. With a strong commitment to research and development, Resonance Health continues to develop cutting-edge solutions that improve patient outcomes and streamline healthcare processes. As a trusted name in the industry, Resonance Health Ltd. has gained recognition globally for its advanced medical imaging products and services.
Resonance Health Ltd, a leading company in the healthcare sector, has accomplished several significant milestones. One noteworthy achievement is the development of FerriScan®, an advanced diagnostic tool for measuring liver iron concentration. Through extensive research and innovative technology, Resonance Health Ltd has revolutionized the diagnosis and monitoring of iron overload disorders such as hereditary hemochromatosis and thalassemia. The company has also expanded its global presence by establishing partnerships with renowned medical institutions and securing regulatory approvals for its groundbreaking products. With a relentless commitment to advancing patient care, Resonance Health Ltd continues to make remarkable strides in the field of medical diagnostics.
Resonance Health Ltd is primarily present in multiple countries and regions across the world. With its global reach, the company has established a strong presence in key markets. Its operations span across Australia, the United States, Europe, and Asia-Pacific regions. Resonance Health Ltd's commitment to expanding its footprint internationally has enabled it to serve a diverse range of customers and collaborate with partners on a global scale. This global presence reinforces Resonance Health Ltd's position as a leading player in the industry while allowing it to leverage various market opportunities and better serve its stakeholders.
Resonance Health Ltd represents values of innovation, excellence, and integrity in its corporate philosophy. As a leading stock health company, Resonance Health Ltd focuses on utilizing advanced technology and research to improve the diagnosis and treatment of liver diseases and iron disorders. With a dedicated team of experts, the company prioritizes accuracy and efficiency in its solutions, delivering reliable results to healthcare professionals worldwide. Resonance Health Ltd strives to enhance patient care by providing precise diagnostic tools, earning recognition for its commitment to quality and advancing medical knowledge.
Dengan kurs saat ini, saham Resonance Health diperdagangkan pada 0,05 EUR (0,08 AUD).
Saham Resonance Health (RHT.AX) tercatat di 1 bursa, termasuk: ASX (RHT.AX).
Resonance Health Ltd is a medical technology and software company specializing in the development and marketing of medical imaging devices, software, and services. The company is based in Perth, Australia, and operates worldwide.
Pendapatan dari Resonance Health adalah 15,75 Juta. AUD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba dari Resonance Health adalah 1,51 Juta. AUD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Resonance Health saat ini adalah 25,50. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Resonance Health.
Rasio harga-terhadap-penjualan (PSR) Resonance Health saat ini adalah 2,45. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Resonance Health.
Skor Kualitas AlleAktien untuk Resonance Health adalah 5/10.
ISIN dari Resonance Health adalah AU000000RHT2. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Resonance Health adalah A0BK8V. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Resonance Health adalah RHT.AX. Simbol ticker digunakan untuk memperdagangkan saham Resonance Health di bursa saham.
Saham Resonance Health
Kelompok Peer Resonance Health
Resonance Health Ticker
Resonance Health FIGI
Semua metrik fundamental dan analisis mendalam Resonance Health
Analisis saham kami untuk saham Resonance Health mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Resonance Health. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.